APA (7th ed.) Citation

Nicolini, S., Bodei, L., Bongiovanni, A., Sansovini, M., Grassi, I., Ibrahim, T., . . . Paganelli, G. (2021). Combined use of 177Lu-DOTATATE and metronomic capecitabine (Lu-X) in FDG-positive gastro-entero-pancreatic neuroendocrine tumors. European journal of nuclear medicine and molecular imaging, 48(10), 3260-3267. https://doi.org/10.1007/s00259-021-05236-z

Chicago Style (17th ed.) Citation

Nicolini, Silvia, et al. "Combined Use of 177Lu-DOTATATE and Metronomic Capecitabine (Lu-X) in FDG-positive Gastro-entero-pancreatic Neuroendocrine Tumors." European Journal of Nuclear Medicine and Molecular Imaging 48, no. 10 (2021): 3260-3267. https://doi.org/10.1007/s00259-021-05236-z.

MLA (9th ed.) Citation

Nicolini, Silvia, et al. "Combined Use of 177Lu-DOTATATE and Metronomic Capecitabine (Lu-X) in FDG-positive Gastro-entero-pancreatic Neuroendocrine Tumors." European Journal of Nuclear Medicine and Molecular Imaging, vol. 48, no. 10, 2021, pp. 3260-3267, https://doi.org/10.1007/s00259-021-05236-z.